N-terminal proatrial natriuretic factor. An independent predictor of long-term prognosis after myocardial infarction.

No abstract is available for this paper.

• Publication year

  1994

• Venue

  Circulation

• Publication date

  1994-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1161/01.CIR.89.5.1934PMID 8181115
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Comparative study of atrial peptides ANF (1-98) and ANF (99-126) as diagnostic markers of atrial distension in patients with cardiac disease.

  1993cited by this paper
• Plasma Atrial Natriuretic Peptide Is Unstable Under Most Storage Conditions

  1992cited by this paper
• Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators.

  1992cited by this paper
• Plasma concentration of atrial natriuretic peptide at admission and risk of cardiac death in patients with acute myocardial infarction

  1992cited by this paper
• Atrial natriuretic peptide levels in the prediction of congestive heart failure risk in frail elderly.

  1992cited by this paper
• Receptors of atrial natriuretic factor.

  1992cited by this paper
• Release of ANF, proANF 1-98, and proANF 31-67 from isolated rat atria by atrial distension.

  1991cited by this paper
• Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality

  1991cited by this paper
• Rationale, design and baseline characteristics of the survival and ventricular enlargement trial. SAVE Investigators.

  1991cited by this paper
• Activation of neurohumoral systems following acute myocardial infarction.

  1991cited by this paper
• Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure.

  1991cited by this paper
• A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure.

  1991cited by this paper
• Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. CONSENSUS Trial Study Group.

  1990cited by this paper
• Prognostic importance of atrial natriuretic peptide in patients with chronic heart failure.

  1989cited by this paper
• Atrial wall function and plasma atriopeptin during volume expansion in conscious dogs.

  1989cited by this paper
• The N-terminus and a 4,000-MW peptide from the midportion of the N-terminus of the atrial natriuretic factor prohormone each circulate in humans and increase in congestive heart failure.

  1989cited by this paper
• Identification and plasma concentrations of the N-terminal fragment of proatrial natriuretic factor in man.

  1988cited by this paper
• Atrial stretch, not pressure, is the principal determinant controlling the acute release of atrial natriuretic factor.

  1988cited by this paper
• Gamma-atrial natriuretic polypeptide (gamma ANP)-derived peptides in human plasma: cosecretion of N-terminal gamma ANP fragment and alpha ANP.

  1988cited by this paper
• NH2-terminal fragment of rat pro-atrial natriuretic factor in the circulation: identification, radioimmunoassay and half-life.

  1988cited by this paper
• The propeptide Asn1-Tyr126 is the storage form of rat atrial natriuretic factor.

  1987cited by this paper
• The hydrolysis of alpha-human atrial natriuretic peptide by pig kidney microvillar membranes is initiated by endopeptidase-24.11.

  1987cited by this paper
• Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction.

  1987cited by this paper
• Differential long-term intrarenal and neurohormonal effects of captopril and prazosin in patients with chronic congestive heart failure: importance of initial plasma renin activity.

  1986cited by this paper
• Metabolic clearance rate and plasma half life of alpha-human atrial natriuretic peptide in man.

  1986cited by this paper
• Plasma alpha natriuretic peptide in cardiac impairment.

  1986cited by this paper
• Heterologous radioimmunoassay of atrial natriuretic polypeptide in dog and rabbit plasma.

  1986cited by this paper
• Molecular forms of atrial natriuretic polypeptides in mammalian tissues and plasma.

  1985cited by this paper
• Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure.

  1984cited by this paper
• Release of natriuretic factor from rat heart-lung preparation by atrial distension.

  1984cited by this paper
• The amino acid sequence of an atrial peptide with potent diuretic and natriuretic properties.

  1983cited by this paper
• A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats.

  1981cited by this paper
• Wall stress and patterns of hypertrophy in the human left ventricle.

  1975cited by this paper

• Comment on "Factors affecting STEMI performance within six hospitals in one healthcare system".

  2022cites this paper
• Cardiovascular Biomarkers: Lessons of the Past and Prospects for the Future

  2022cites this paper
• Higher galectin-3 levels are independently associated with lower anxiety in patients with risk factors for heart failure

  2020cites this paper
• Endothelin-Antagonisten in der neurohumoralen Therapie der chronischen Herzinsuffizienz

  2020cites this paper
• Pilot Trial Evaluating Mid-Regional Pro-Atrial Natriuretic Peptide as a Marker of Sepsis after Abdominal Surgery

  2018cites this paper
• Novel biomarkers of cardiovascular disease: Applications in clinical practice

  2018cites this paper
• Post-Operative Haemodynamic and Neurohumoral Follow-Up After

  2018cites this paper
• Midregional pro-A-type natriuretic peptide as part of a dual biomarker strategy for the early rule out of non-ST segment elevation acute coronary syndrome - The WilCop study.

  2018cites this paper
• Combined baseline and one-month changes in big endothelin-1 and brain natriuretic peptide plasma concentrations predict clinical outcomes in patients with left ventricular dysfunction after acute myocardial infarction: Insights from the Eplerenone Post-Acute Myocardial Infarction Heart Failure Effic

  2017cites this paper
• Congestive Heart Failure Beneficial Neurohormonal Profile of Spironolactone in Severe Congestive Heart Failure

  2016cites this paper
• Role of Plasma N-Terminal Pro-Brain Natriuretic Peptide ( NT-proBNP ) Levels in Cirrhotic Patients with Sepsis

  2016cites this paper
• Biomarkers atriuretic Peptides as Predictors of on-Sudden and Sudden Cardiac Death After cute Myocardial Infarction in the Beta-Blocking Era

  2016cites this paper
• Serum levels of NT- pro ANP, BNP, NT-pro BNP and function of the left atrium in patients with heart failure and preserved ejection fraction after myocardial infarction

  2015cites this paper
• Mineralocorticoid receptor antagonism in acutely decompensated chronic heart failure.

  2014cites this paper
• Beneficial neurohumoral profile in left ventricular systolic dysfunction following acute myocardial infarction

  2014cites this paper
• Association of aortic stiffness with biomarkers of myocardial wall stress after myocardial infarction.

  2014cites this paper
• High-Sensitivity Troponin T: A Biomarker for Diuretic Response in Decompensated Heart Failure Patients

  2014cites this paper
• Assessment of the left atrial volume index and plasma NT-proANP level in patients with acute ST-elevation myocardial infarction

  2013cites this paper
• Hypertension in Growth Hormone Excess and Deficiency

  2013cites this paper
• Myocardial Performance and its Acute Response to Angiotensin II Infusion in Fetal Sheep Adapted to Chronic Anemia

  2012cites this paper
• Effects of ethanolic extract from Radix Scrophulariae on ventricular remodeling in rats.

  2012cites this paper
• Natriuretic peptides: Diagnostic and therapeutic use

  2011cites this paper
• Decompensated Heart Failure Is Associated With Reduced Corin Levels and Decreased Cleavage of Pro–Atrial Natriuretic Peptide

  2011cites this paper
• after acute myocardial infarction in the beta-blocking era Natriuretic peptides as predictors of non-sudden and sudden cardiac death

  2011cites this paper
• Improved pharmacological therapy of chronic heart failure in primary care: a randomized Study of NT‐proBNP Guided Management of Heart Failure – SIGNAL‐HF (Swedish Intervention study – Guidelines and NT‐proBNP AnaLysis in Heart Failure)

  2010cites this paper
• Novel iodinated tracers, MIBG and BMIPP, for nuclear cardiology

  2010cites this paper
• Clinical Medicine insights: Cardiology comparison of n-Terminal pro B-natriuretic peptide and echocardiographic Indices in patients with Mitral Regurgitation

  2010cites this paper
• BNP-guided vs symptom-guided heart failure therapy: the Trial of Intensified vs Standard Medical Therapy in Elderly Patients With Congestive Heart Failure (TIME-CHF) randomized trial.

  2009cites this paper
• Procédé in vitro pour le diagnostic, le pronostic, la surveillance et le suivi thérapeutique des troubles liés au syndrome métabolique, à une maladie cardiovasculaire et/ou à une résistance à l'insuline

  2009cites this paper
• Prognosis and risk assessment in stroke patients by determining the level of marker peptides

  2009cites this paper
• Post‐myocardial Infarction Intraventricular Conduction Defects and B‐type Natriuretic Peptide Levels

  2009cites this paper
• Diagnostic utility of plasma N-terminal pro-B-type natriuretic peptide and C-reactive protein levels in differential diagnosis of pericardial constriction and restrictive cardiomyopathy.

  2009cites this paper
• TIME-CHF ) Randomized Trial Elderly Patients With Congestive Heart Failure The Trial of Intensified vs Standard Medical Therapy in BNP-Guided vs Symptom-Guided Heart Failure Therapy :

  2009cites this paper
• The prognostic value of atrial and brain natriuretic peptides, troponin I and C-reactive protein in patients with sepsis.

  2008cites this paper
• Midregional pro-atrial natriuretic peptide is a useful indicator for the detection of impaired left ventricular function in patients with coronary artery disease.

  2008cites this paper
• Analytical validation of commercial immunoassays for the measurement of cardiovascular peptides in the dog.

  2008cites this paper
• Pharmacokinetic and pharmacodynamic effects of midodrine on blood pressure, the autonomic nervous system, and plasma natriuretic peptides: a prospective, randomized, single-blind, two-period, crossover, placebo-controlled study.

  2008cites this paper
• Plasma N-terminal B type natriuretic peptide as an Indicator of Long-term Survival After Acute Myocardial Infarction : Comparison With Plasma Mid-regional Pro-atrial Natriuretic Peptide-Leicester Acute Myocardial Infarction Peptide ( LAMP ) Study

  2008cites this paper
• Plasma N-terminal B-Type natriuretic peptide as an indicator of long-term survival after acute myocardial infarction: comparison with plasma midregional pro-atrial natriuretic peptide: the LAMP (Leicester Acute Myocardial Infarction Peptide) study.

  2008cites this paper
• Atrial Natriuretic Peptide, a Regulator of Nuclear Factor-κB Activation in Vivo

  2007cites this paper
• Decreased Myocardial β-Adrenergic Receptor Density in Relation to Increased Sympathetic Tone in Patients with Nonischemic Cardiomyopathy

  2007cites this paper
• [Diabetes and heart failure, a fatal association].

  2007cites this paper
• Prognostic value of N-terminal pro-B-type natriuretic peptide in patients with active infective endocarditis.

  2007cites this paper
• Percutaneous coronary revascularization reduces plasma N-terminal pro-B-type natriuretic peptide concentration in stable coronary artery disease.

  2007cites this paper
• Atrial natriuretic peptide, a regulator of nuclear factor-kappaB activation in vivo.

  2007cites this paper
• Wartość prognostyczna analizy poliformizmu genów układu renina-angiotensyna, glikoprotein płytkowych oraz przedsionkowego czynnika natriuretycznego w przewidywaniu częstości występowania incydentów sercowo-naczyniowych w kohorcie pracowników Portu Gdańskiego w 8- letniej obserwacji

  2007cites this paper
• Thee role of natriuretic peptides in the diagnosis and treatment off patients with carcinoid heart disease

  2007cites this paper
• Functional capacity and changes in the neurohormonal and cytokine status after long-term CRT in heart failure patients.

  2007cites this paper
• Prognostic value of B-Type natriuretic peptides in patients with stable coronary artery disease: the PEACE Trial.

  2007cites this paper
• A comparison of low versus high heart rate in patients with atrial fibrillation and advanced chronic heart failure: effects on clinical profile, neurohormones and survival.

  2006cites this paper
• Natriuretic Peptides in Acute and Chronic Coronary Artery Disease

  2006cites this paper
• Gene expression, processing, and secretion of natriuretic peptides: physiologic and diagnostic implications.

  2006cites this paper
• Use of Antioxidants in Patients with Congestive Heart Failure

  2006cites this paper
• Servicio de Arritmias del Centro de Asistencia del Sindicato MØdico del Uruguay-Instituto Nacional de CirugÌa CardÌaca. Montevideo, Uruguay ¿Se puede predecir el riesgo de muerte sœbita luego de sufrir un infarto de miocardio?

  2006cites this paper
• Risk assessment in patients with unstable angina/non-ST-elevation myocardial infarction and normal N-terminal pro-brain natriuretic peptide levels by N-terminal pro-atrial natriuretic peptide.

  2005cites this paper
• The association between NT-proBNP levels, functional capacity and stage in patients with heart failure

  2005cites this paper
• Determinants of Natriuretic Peptide Production by the Heart

  2005cites this paper
• Growth hormone and fluid homeostasis.

  2005cites this paper
• Determinants of Natriuretic Peptide Production by the Heart

  2005cites this paper
• Neurohormonal risk stratification for sudden death and death owing to progressive heart failure in chronic heart failure

  2005cites this paper
• Early Responses to Oxidative Stress In Heart Cells: Signals From The Cell Membrane To The Nucleus and Beyond

  2005cites this paper
• Serum N‐Terminal pro‐BNP Levels Correlate with Symptoms and Echocardiographic Findings in Patients with Mitral Stenosis

  2005cites this paper
• Prognostic Value of Plasma N-Terminal Pro-Brain Natriuretic Peptide in Patients With Severe Sepsis

  2005cites this paper
• A direct comparison of the natriuretic peptides and their relationship to survival in chronic heart failure of a presumed non‐ischaemic origin

  2005cites this paper
• Increased plasma levels of NT-proANP and NT-proBNP as markers of cardiac dysfunction in septic patients.

  2005cites this paper
• Chapter 18 – Natriuretic Peptides

  2005cites this paper
• Neurohormonal activation in populations susceptible to heart failure.

  2005cites this paper
• Incidence of normal values of natriuretic peptides in patients with chronic heart failure and impact on survival: A direct comparison of N‐terminal atrial natriuretic peptide, N‐terminal brain natriuretic peptide and brain natriuretic peptide

  2005cites this paper
• Opposite effects of losartan and atenolol on natriuretic peptides in patients with hypertension and left ventricular hypertrophy: a LIFE substudy

  2005cites this paper
• Plasma natriuretic peptides up to 2 years after acute myocardial infarction and relation to prognosis: an OPTIMAAL substudy.

  2005cites this paper
• Carvedilol therapy is associated with a sustained decline in brain natriuretic peptide levels in patients with congestive heart failure.

  2005cites this paper
• Heart rate reduction by zatebradine reduces infarct size and mortality but promotes remodeling in rats with experimental myocardial infarction.

  2004cites this paper
• Diastolic dysfunction and ANP/BNP levels

  2004cites this paper
• Implications of the natriuretic peptide system in the pathogenesis of heart failure: diagnostic and therapeutic importance.

  2004cites this paper
• N‐terminal proBNP and mortality in hospitalised patients with heart failure and preserved vs. reduced systolic function: data from the prospective Copenhagen Hospital Heart Failure Study (CHHF)

  2004cites this paper
• Science review: Natriuretic peptides in critical illness

  2004cites this paper
• Cardiovascular Effects of Natriuretic Peptides and Their Interrelation with Endothelin-1

  2004cites this paper
• FELINE ATRIAL NATRIURETIC PEPTIDE (ANP) HAS A SINGLE COPY GENE

  2004cites this paper
• [Natriuretic peptides--new diagnostic markers in heart disease].

  2004cites this paper
• Neurohumoral and hemodynamic effects of the selective endothelin antagonist darusentan in advanced chronic heart failure.

  2004cites this paper
• Natriuretic peptides as predictors of non-sudden and sudden cardiac death after acute myocardial infarction in the beta-blocking era.

  2004cites this paper
• Biochemical analysis of neutral endopeptidase activity reveals independent catabolism of atrial and brain natriuretic peptide

  2004cites this paper
• Endocrine and paracrine aspects of vascular control : the effects of natriuretic peptides on human capacitance in health and chronic heart failure

  2004cites this paper
• N-terminal pro-brain natriuretic peptide predicts cardiovascular events in patients with hypertension and left ventricular hypertrophy: a LIFE study

  2004cites this paper
• Superiority of big endothelin-1 and endothelin-1 over natriuretic peptides in predicting survival in severe congestive heart failure: a 7-year follow-up study.

  2004cites this paper
• N-terminal pro-atrial natriuretic peptide as a biochemical marker of long-term interventional success after radiofrequency catheter ablation of paroxysmal supraventricular tachyarrhythmias

  2004cites this paper
• N-terminal proatrial natriuretic peptide predicts two-year remodelling in patients with acute transmural myocardial infarction.

  2004cites this paper
• Role of natriuretic peptides in the diagnosis and treatment of patients with carcinoid heart disease

  2004cites this paper
• Natriuretic Peptides and Endothelin in Aortic Stenosis and Heart Transplantation

  2004cites this paper
• Relation of ANP and BNP to their N‐terminal fragments in fetal circulation: evidence for enhanced neutral endopeptidase activity and resistance of BNP to neutral endopeptidase in the fetus

  2004cites this paper
• Elevated D-dimer level is an independent risk factor for cardiovascular death in out-patients with symptoms compatible with heart failure

  2004cites this paper
• Natriuretische Peptide—neue diagnostische Marker bei Herzerkrankungen

  2004cites this paper
• N-terminal pro-atrial natriuretic peptide (N-ANP) and N-terminal pro-B-type natriuretic peptide (N-BNP) in the prediction of death and heart failure in unselected patients following acute myocardial infarction.

  2004cites this paper
• Diagnostic and prognostic usefulness of natriuretic peptides in emergency department patients with dyspnea.

  2003cites this paper
• Cardiovascular Autonomic Regulation in Patients with Sustained Hypertension of Different Etiology and Severity (Kardiovaskulaarinen autonominen säätely etiologialtaan ja vaikeusasteeltaan erityyppisissä hypertensioissa)

  2003cites this paper
• Ventricular remodeling does not accompany the development of heart failure in diabetic patients after myocardial infarction.

  2003cites this paper
• Increased Plasma Natriuretic Peptide Levels Reflect Symptom Onset in Aortic Stenosis

  2003cites this paper
• Non-invasive predictors of mortality after acute myocardial infarction

  2003cites this paper
• Cardiac hormones as diagnostic tools in heart failure.

  2003cites this paper
• Plasma catecholamines and N-terminal proBNP in patients with acute myocardial infarction undergoing primary angioplasty

  2003cites this paper